Bluejay Diagnostics (BJDX) Operating Expenses (2020 - 2026)

Bluejay Diagnostics has disclosed Operating Expenses across 7 years of filings, most recently posting $1.9 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $1.9 million, up 2.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 5.62% YoY), and the FY2025 annual result was $7.0 million, down 3.02% from the prior year.
• Operating Expenses came in at $1.9 million for Q1 2026 at Bluejay Diagnostics, up from $1.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.8 million in Q3 2022 to a low of $336.0 in Q2 2023.
• The 5-year median for Operating Expenses is $2.0 million (2025), against an average of $1.9 million.
• Across the five-year window, Operating Expenses tumbled 99.98% in 2023 and surged 563965.77% in 2024, its largest moves.
• Bluejay Diagnostics' Operating Expenses stood at $2.5 million in 2022, then retreated by 2.73% to $2.4 million in 2023, then slumped by 37.8% to $1.5 million in 2024, then retreated by 1.54% to $1.5 million in 2025, then soared by 32.64% to $1.9 million in 2026.
• The last three Operating Expenses figures came in at $1.9 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.